⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BLLN News
BillionToOne, Inc. Class A Common Stock
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
prnewswire.com
BLLN
Form 8-K
sec.gov
BLLN
BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
globenewswire.com
BLLN
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
prnewswire.com
BLLN
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
globenewswire.com
BLLN
Form 8-K
sec.gov
BLLN
BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
prnewswire.com
BLLN
Form 8-K
sec.gov
BLLN
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
globenewswire.com
BLLN
Form 8-K
sec.gov
BLLN